Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a…

Overview of attention for article published in Breast Cancer Research, July 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

blogs: 1 blog

twitter: 3 X users

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 95 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,190 followers.

Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: via @BioMedCentral #BreastCancer #Cancer #Medicine #Science #Health https://t.co/KYA3d0Mxke

28 Jul 2020

Reply Repost Favourite

RT @breastguide: Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining th…

23 Jul 2020

Reply Repost Favourite

Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines | https://t.co/L

22 Jul 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.